As of October 13, 2025, Ozon Pharmaceuticals shares have been included in the Moscow Exchange’s first-tier quotation list following the October 9 decision. In 2025, the company conducted an SPO of 65.9 million shares and completed an additional issue, raising its free float to 14%. This met the Exchange’s first-tier criteria. The inclusion broadens the investor base and improves liquidity, said the Group’s Investor Relations Director Dmitry Kovalenko.